New blood test could help detect and locate cancer early on

March 6, 2017, University of California - San Diego
Credit: public domain

Bioengineers at the University of California San Diego have developed a new blood test that could detect cancer—and locate where in the body the tumor is growing.

The study could provide a way to diagnose early on without having to do invasive surgical procedures like biopsies. Researchers published their findings March 6 in Nature Genetics.

Cancer tests work by screening for DNA released by dying cells. These tests are showing promise for detecting traces of tumor DNA in the blood of cancer patients. However, the results don't indicate where the tumor resides. "Knowing the tumor's location is critical for effective early detection," said Kun Zhang, a bioengineering professor at the UC San Diego Jacobs School of Engineering and senior author of the study.

In this study, Zhang and his team discovered a new clue in blood that could both detect and identify where they are. When a tumor starts to take over a part of the body, it competes with normal cells for nutrients and space, killing them off in the process. As normal cells die, they release their DNA into the bloodstream—and that DNA could identify the affected tissue.

The method screens for a particular DNA signature called CpG methylation haplotypes, which are the addition of methyl groups to multiple adjacent CG sequences in a DNA molecule. Each tissue in the body can be identified by its unique signature of methylation haplotypes.

"We made this discovery by accident. Initially, we were taking the conventional approach and just looking for cancer cell signals and trying to find out where they were coming from. But we were also seeing signals from other cells and realized that if we integrate both sets of signals together, we could actually determine the presence or absence of a tumor, and where the tumor is growing," Zhang said.

To develop their new method, the researchers put together a database of the complete CpG methylation patterns of 10 different normal tissues (liver, intestine, colon, lung, brain, kidney, pancreas, spleen, stomach and blood). They also analyzed tumor samples and blood samples from cancer patients at the UC San Diego Moores Cancer Center to put together a database of cancer-specific genetic markers.

Zhang and his team then screened blood samples from individuals with and without tumors. They looked for signals of the cancer markers and the tissue-specific . The test works like a dual authentication process—the combination of both signals, above a statistical cutoff, is required to assign a positive match.

"This a proof of concept. To move this research to the clinical stage, we need to work with oncologists to further optimize and refine this method," Zhang said.

Explore further: Simple blood tests can help detect, target cancer: study

More information: "Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA," Nature Genetics (2017).DOI: 10.1038/ng.3805

Related Stories

Simple blood tests can help detect, target cancer: study

June 4, 2016
Blood samples can be just as effective as invasive tissue biopsies in monitoring cancer and can help doctors better prescribe treatment, a study revealed Saturday.

Researchers identify striking genomic signature shared by five types of cancer

February 5, 2016
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer. They also found evidence that this methylation signature may be present in many more ...

Hybrid immune cells in early-stage lung cancer spur anti-tumor T cells to action

July 14, 2016
The microenvironment of tumors is a mix of cell types, mostly comprised of inflammatory cells. White blood cells, recruited from the blood and bone marrow, represent a significant portion of these inflammatory cells and influence ...

Tumor blood vessel protein provides potential therapeutic target

August 27, 2014
Tumor blood vessels supply oxygen and nutrients to cancer cells and provide access to other organs. While tumor vasculature shares many features with normal vessels, their unique characteristics are potential therapeutic ...

Breast cancer tumor-initiating cells use mTOR signaling to recruit suppressor cells to promote tumor

May 16, 2016
Not every breast cancer tumor follows the same path to grow. Some tumors have the assistance of myeloid-derived suppressor cells (MDSCs), a diverse type of immune cell involved in the suppression of the body's response against ...

Life-preserver microbubbles float tumor cells for analysis

April 18, 2016
A University of Colorado Cancer Center study presented at the American Association for Cancer Research Annual Meeting 2016 demonstrates the use of gas microbubbles to selectively attach to and float circulating tumor cells ...

Recommended for you

Scientists develop 'world first' melanoma blood test

July 18, 2018
Australian researchers said Wednesday they have developed a blood test for melanoma in its early stages, calling it a "world first" breakthrough that could save many lives.

Early supper associated with lower risk of breast and prostate cancer

July 18, 2018
Having an early supper or leaving an interval of at least two hours before going to bed are both associated with a lower risk of breast and prostate cancer. Specifically, people who take their evening meal before 9 p.m. or ...

Magnetized wire could be used to detect cancer in people, scientists report

July 16, 2018
A magnetic wire used to snag scarce and hard-to-capture tumor cells could prove to be a swift and effective tactic for early cancer detection, according to a study by researchers at the Stanford University School of Medicine.

Researchers suggest new treatment for rare inherited cancers

July 16, 2018
Studying two rare inherited cancer syndromes, Yale Cancer Center (YCC) scientists have found the cancers are driven by a breakdown in how cells repair their DNA. The discovery, published today in Nature Genetics, suggests ...

Researchers map 'family trees' of acute myeloid leukemia

July 16, 2018
For the first time, a team of international researchers has mapped the family trees of cancer cells in acute myeloid leukaemia (AML) to understand how this blood cancer responds to a new drug, enasidenib. The work also explains ...

Scientists sharpen the edges of cancer chemotherapy with CRISPR

July 13, 2018
Tackling unsolved problems is a cornerstone of scientific research, propelled by the power and promise of new technologies. Indeed, one of the shiniest tools in the biomedical toolkit these days is the genome editing system ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.